1. Home
  2. Labeler Index
  3. Patheon Softgels Inc.
  4. 10888-8169
  5. NDC Package Code: 10888-8169-1 Ethosuximide

NDC Package 10888-8169-1 Ethosuximide

Capsule - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
10888-8169-1
Package Description:
14000 CAPSULE in 1 CASE
Product Code:
10888-8169
Non-Proprietary Name:
Ethosuximide
Substance Name:
Ethosuximide
Usage Information:
This medication is used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.
11-Digit NDC Billing Format:
10888816901
Product Type:
Drug For Further Processing
Labeler Name:
Patheon Softgels Inc.
Dosage Form:
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Active Ingredient(s):
  • ETHOSUXIMIDE 250 mg/1
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    05-28-2010
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 10888-8169-1?

    The NDC Packaged Code 10888-8169-1 is assigned to an UNFINISHED drug package of 14000 capsule in 1 case of Ethosuximide, drug for further processing labeled by Patheon Softgels Inc.. The product's dosage form is capsule and is administered via form.

    Is NDC 10888-8169 included in the NDC Directory?

    Yes, Ethosuximide is an UNFINISHED PRODUCT with code 10888-8169 that is active and included in the NDC Directory. The product was first marketed by Patheon Softgels Inc. on May 28, 2010 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 10888-8169-1?

    The 11-digit format is 10888816901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-110888-8169-15-4-210888-8169-01